|
|
|
|
| |
|
|
|
|
|
|
January - March |
April
- June | July - September | October - Decembar
|
|
|
2009 Us TOO
HotSheet Article Index
|
|
|
|
|
|
|
January
| View Newsletter
|
February
| View Newsletter
|
March
| View Newsletter
|
|
Includes:
-
Diagnoses of Cancer Decline in the US
-
Cleveland Clinic Unveils ‘Top 10’ Medical Innovations for 2009
-
Antidiabetic Drugs Linked to Lower Risk of Prostate Cancer
-
Index of Articles Appearing in the 2008 Us TOO HotSheets
-
Doc Moyad’s “What Works and What Is Worthless Column”— The JUPITER trial
-
PSA Doubling Time and Time to Biochemical Failure May Predict Prostate Cancer-Specific Mortality
-
Read
more..
|
Includes:
-
Us TOO Names 2009 Board Officers & Members
-
FDA Approves Ferring Pharmaceuticals’ Degarelix (generic name) for Advanced Prostate Cancer
-
Geography’s Role in Medicare Cancer Coverage
-
Low-Income Men More Often Diagnosed with Advanced Prostate Cancer
-
FDA Commissioner to Step Down
-
Us TOO Pleasanton, California Chapter Honors Memory of Bill Stone
-
The Doctor’s Note—Dr. Gerald Chodak
-
Read
more..
|
Includes:
-
Medicare Widens Drugs It Accepts for Cancer
-
Experts Urge Prostate Cancer “Man-o-Gram’
-
Prostate Cancer and Neglect of Other Illnesses
-
Thalidomide for the Treatment of Biochemically Recurrent Prostate Cancer
-
Adjuvant Radiotherapy Improves Survival after Radical Prostatectomy
-
Donated Items Sought for June Online Auction
-
Family History of Prostate Cancer Does Not Affect Treatment Outcomes
-
Read
more..
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April | View Newsletter
|
MAY | View Newsletter
|
June | View Newsletter
|
|
Includes:
-
Stop PSA Screening in Men Over 75 — But Only Those With Low PSA, Says New Study
-
Researchers Identify Biomarker for Fatal Prostate Cancer
-
Costs Force Cancer Survivors to Pass on Health Care
-
Molecule’s Prevalence May Aid in Deciding Whether to Treat Prostate Cancer
-
GTx Announces Phase III Clinical Development of Toremifene 20 mg on Course Following Safety Review
-
Preventing Prostate Cancer: Good Nutrition May Be Key
-
Personalized Calculator for Future Prostate Cancer Risk
-
Read
more..
|
Includes:
-
What to Make of the Prostate Cancer Screening Studies
-
A Joint Statement from America’s Prostate Cancer Advocacy, Education and Support Organizations
-
Leading US-Based Prostate Cancer Organizations Develop Joint Policy Agenda
-
PSA Has Higher Predictive Ability in Black Men than in White Men
-
Highlights from the 2009 ASCO GU Cancers Symposium
-
Selected Men with Low-Risk Prostate Cancer Have Good Clinical Outcomes without Immediate Treatment
-
The Doctor’s Note — Dr. Gerald Chodak
-
Read
more..
|
Includes:
-
Urologists Support Baseline PSA Test at Age 40
-
Provenge® Significantly Improves Survival
-
Living and Loving with Prostate Cancer
-
Us TOO Seeks Board Member Applications
-
Statins May Protect Prostate Health
-
Race May Not Be Key in Cancer Disparities
-
Gene Variant Linked to Aggressive Cancers
-
Agent Orange & Rapidly Recurrent Cancer
-
NCI’s Plan to Accelerate Cancer Research
-
Read
more..
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July | View Newsletter
|
August | View Newsletter
|
September |
View Newsletter
|
|
Includes:
-
Signposts Brochure Now Available
-
Young Men with Advanced Cancer & Prognosis
-
False Positives in Screening Reduced by New Test
-
Predicting Prostate Cancer Recurrence
-
Combidex® & Lymph Node Metastasis
-
Us TOO Seeks Board Member Applications
-
Prostate Cancer Yet Another Worry for Women
-
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
-
Read
more..
|
Includes:
-
New Urinary Continence Brochure Available
-
Prostate Cancer Patients Should Not Take Selenium
-
Test Improves Prediction of Disease Course
-
Predicting the Return of Prostate Cancer
-
Prostate Cancer Screening: A Question of Common Sense — Dr. Louis Denis, Us TOO Belgium
-
Men with Post-RP pT3 Disease & An Undetectable PSA Benefit from Adjuvant Radiation Therapy
-
Prostate Shrinkage May Reveal High-Grade Cancer
-
Read
more..
|
Includes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October
| View Newsletter
|
November | View Newsletter
|
December | View Newsletter
|
|
Includes:
-
Denosumab Prevents Fractures in Men with Non-Metastatic Prostate Cancer Receiving ADT
-
Coronary Artery Disease Risks with ADT
-
FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs
-
‘Watchful Waiting’ Is a Viable Option for Prostate Cancer Patients with Low-Risk Tumors
-
PET/CT Scans May Help Detect Recurring Prostate Cancer Earlier
-
Robotic Surgery May Improve Functional Outcome
-
Larry King Live Video Discusses Early Detection of Prostate Cancer Using the PSA Test
-
Doc Moyad’s “What Works and What Is Worthless Column”— Coenzyme Q10
-
Read
more..
|
Includes:
-
Link Found Between Common Sexual Infection and Risk of Aggressive Prostate Cancer
-
Every Mustache Makes a Difference
-
New Web-Based Us TOO Prostate Cancer Support Community
-
Soy Pills Fail to Prevent Bone Loss
-
Men Diagnosed with Prostate Cancer in Recent Years Have Better Survival Outcomes
-
Getting Closer to the Origins of Prostate Cancer
-
Protein Tied with Aggressive Prostate Cancer
-
5th Annual Chicago SEA Blue Prostate Cancer Walk
Doc Moyad’s “What Works and What Is Worthless Column”— For BPH, Drugs Are Better than Herbs -
Read
more..
|
Includes:
-
Doc Moyad’s “No Bogus Science” Column—Why I Donate to Us TOO International
-
AUA Releases Statement Clarifying Prostate Cancer Testing Recommendations
-
Dendreon Completes Submission of Biologics License Application for PROVENGE®
-
Questions on Breast & Prostate Cancer Screening
-
American Cancer Society Stands by its Screening Guidelines; Mammograms for Women Encouraged
-
FDA Says No to Amgen Bone Drug
-
Radical Prostatectomy Finding in Patients Who Fail Active Surveillance for Prostate Cancer
-
Clinicians Map Group at High Risk for Aggressive “Hidden” Prostate Cancer
-
Read
more..
|
|
|
|
|
|
|
|
|
|
|
